Lymphocyte/mean platelet volume ratio, a new marker; is it effective in predicting the prognosis of COVID-19 cases? | Zendy

Suna Eraybar | Zendy; Melih Yüksel | Zendy; Hüseyin Aygün | Zendy; Mehmet Oğuzhan Ay | Zendy; Hasan Kaya | Zendy; Muhammet Bulut | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lymphocyte/mean platelet volume ratio, a new marker; is it effective in predicting the prognosis of COVID-19 cases?

Author(s) -

Suna Eraybar,

Melih Yüksel,

Hüseyin Aygün,

Mehmet Oğuzhan Ay,

Hasan Kaya,

Muhammet Bulut

Publication year - 2021

Publication title -

bratislavské lekárske listy/bratislava medical journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.387

H-Index - 32

eISSN - 1336-0345

pISSN - 0006-9248

DOI - 10.4149/bll_2021_068

Subject(s) - medicine , covid-19 , lymphocyte , gastroenterology , mean platelet volume , receiver operating characteristic , platelet , area under the curve , lymphocyte subsets , disease , immunology , t cell , infectious disease (medical specialty) , immune system

This study aims to determine the prognostic significance of the lymphocyte/mean platelet volume ratio (LMR) in terms of the clinical course of the disease in patients with COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research